Other information and services: www.belgium.be Logo of the Belgian Federal Authorities

Zykadia®

Active substance	Ceritinib
Holder	Novartis Pharma nv
Status	Closed
Indication	ALK positive NSCLC patients that have received prior therapy with crizotinib
Public documents	Approbation
	Information for the patient
	Informed consent
Last update	31/01/2017

Last updated on 10/04/2026

instructions how to enable JavaScript in your web browser